Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2013; 5(01): 38-41
DOI: 10.4103/0974-2727.115934
Original Article

Comparison of Serum Lipid Profiles between Normal Controls and Breast Cancer Patients

Pikul Laisupasin
Division of Pathology, National Cancer Institute, Bangkok, Thailand
,
Warayupa Thompat
Division of Pathology, National Cancer Institute, Bangkok, Thailand
,
Saowakon Sukarayodhin
Division of Research, Biology Section, National Cancer Institute, Bangkok, Thailand
,
Adisak Sornprom
Division of Surgery, National Cancer Institute, Bangkok, Thailand
,
Yuttana Sudjaroen
Faculty of Science and Technology, Suan Sunandha Rajabhat University, Bangkok, Thailand
› Author Affiliations Source of Support: Nil
› Further Information
  PDF Download Permissions and Reprints

ABSTRACT

Background: Researchers have reported association of plasma/serum lipids and lipoproteins with different cancers. Increase levels of circulating lipids and lipoproteins have been associated with breast cancer risk. Aim: The aim of this study is to compare serum lipid profiles: total-cholesterol (T-CHOL), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C) and very low density lipoprotein-cholesterol (VLDL-C) between breast cancer patients and normal participants. Materials and Methods: A total of 403 women in this study were divided into two groups in the period during May 2006-April 2007. Blood samples were collected from 249 patients with early stage breast cancer and 154 normal controls for serum lipid profiles (T-CHOL, TG, HDL-C, LDL-C and VLDL-C) analysis using Hitachi 717 Autoanalyzer (Roche Diagnostic GmbH, Germany). TG, LDL-C and VLDL-C levels in breast cancer group were significantly increased as compared with normal controls group (P < 0.001), whereas HDL-C and T-CHOL levels were not. Results: The results of this study suggest that increased serum lipid profiles may associate with breast cancer risk in Thai women. Further studies to group important factors including, cancer stages, types of cancer, parity, and menopausal status that may affect to lipid profiles in breast cancer patients along with an investigation of new lipid profiles to clarify most lipid factors that may involve in breast cancer development are needed.

Key words:

Breast cancer - lipid profiles - lipoprotein - serum lipids


Publication History

Article published online:
07 April 2020

© 2013.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, et al. Site-specific analysis of total serum cholesterol and incident cancer in the national health and nutrition examination survey I epidemiologic follow-up study. Cancer Res 1988;48:452-8.
  • 2 Gerber M, Richardson S, Crastes de Paulet P, Pujol H, Crastes de Paulet A. Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer 1989;64:2347-53.
  • 3 Forones NM, Falcao JB, Mattos D, Barone B. Cholesterolemia in colorectal cancer. Hepatogastroenterology 1998;45:1531-4.
  • 4 Chyou PH, Nomura AM, Stemmermann GN, Kato I. Prospective study of serum cholesterol and site-specific cancers. J Clin Epidemiol 1992;45:287-92.
  • 5 Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, et al. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer 2004;41:25-31.
  • 6 Bani IA, Williams CM, Boulter PS, Dickerson JW. Plasma lipids and prolactin in patients with breast cancer. Br J Cancer 1986;54:439-46.
  • 7 Knapp ML, al-Sheibani S, Riches PG. Alterations of serum lipids in breast cancer: Effects of disease activity, treatment, and hormonal factors. Clin Chem 1991;37:2093-101.
  • 8 Boyd NF, McGuire V. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 1990;82:460-8.
  • 9 Boyd NF, McGuire V, Fishell E, Kuriov V, Lockwood G, Tritchler D. Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer 1989;59:766-71.
  • 10 Hasija K, Bagga HK. Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem 2005;20:61-6.
  • 11 Paley PJ. Screening for the major malignancies affecting women: Current guidelines. Am J Obstet Gynecol 2001;184:1021-30.
  • 12 Davis DL, Bradlow HL. Can environmental estrogens cause breast cancer? Sci Am 1995;273:167-72.
  • 13 Jamall S, Ishaq M, Mahmood AJ, Khadim M. CA-15-3 and lipid profile in breast cancer patients. Pak J Biochem Mol Biol 2010;43:114-8.
  • 14 Lane DM, Boatman KK, McConathy WJ. Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat 1995;34:161-9.
  • 15 Ray G, Husain SA. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 2001;34:71-6.
  • 16 Agheli N, Therwath A. Nutrition, dietary fat and breast cancer: A review. Indian J Cancer 1994;31:218-25.
  • 17 Høyer AP, Engholm G. Serum lipids and breast cancer risk: A cohort study of 5,207 Danish women. Cancer Causes Control 1992;3:403-8.
  • 18 Kannel WB. Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 1987;59:80A-90.
  • 19 Elkhadrawy TM, Ahsan H, Neugut AI. Serum cholesterol and the risk of ductal carcinoma in situ: A case-control study. Eur J Cancer Prev 1998;7:393-6.